Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Net Margin: 2009-2024

Historic Net Margin for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to 29.25%.

  • Ironwood Pharmaceuticals' Net Margin rose 2886.00% to 32.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 38.49%, marking a year-over-year increase of 9917.00%. This contributed to the annual value of 29.25% for FY2024, which is 31341.00% up from last year.
  • According to the latest figures from FY2024, Ironwood Pharmaceuticals' Net Margin is 29.25%, which was up 110.29% from -284.17% recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Net Margin ranged from a high of 127.72% in FY2021 and a low of -284.17% during FY2023.
  • For the 3-year period, Ironwood Pharmaceuticals' Net Margin averaged around -70.76%, with its median value being 29.25% (2024).
  • In the last 5 years, Ironwood Pharmaceuticals' Net Margin plummeted by 32,679bps in 2023 and then soared by 31,341bps in 2024.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Net Margin stood at 27.25% in 2020, then skyrocketed by 10,047bps to 127.72% in 2021, then plummeted by 8,510bps to 42.63% in 2022, then crashed by 32,679bps to -284.17% in 2023, then surged by 31,341bps to 29.25% in 2024.